Fig. 2From: Nanobody-based CAR-T cells for cancer immunotherapyAn illustration of a human and a llama immunoglobulin G and their applicable derivatives as CAR targeting domains. CH1, heavy chain constant domain 1; CH2, heavy chain constant domain 2; CH3, heavy chain constant domain 3; CL, light chain constant domain; IgG, immunoglobulin G; VH, heavy chain variable domain; VHH, single variable domain on a heavy chain; VL, light chain variable domainBack to article page